Cargando…
A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs
A prevalence threshold to define rare diseases is needed for orphan drug designation. Here, we propose a bottom-up approach to defining rare diseases for China, based on the minimum number of patients needed for the industry to make a reasonable profit on a new drug. To obtain this patient populatio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353681/ https://www.ncbi.nlm.nih.gov/pubmed/25757391 http://dx.doi.org/10.1186/s13023-015-0241-x |